68Ga-DOTA-FAPI与18F-FDG PET/CT检测胃肠道肿瘤肝转移的比较
本研究纳入31例胃肠道肿瘤患者,比较68Ga-DOTA-FAPI与18F-FDG PET/CT对肝转移的诊断效能。患者水平真阳性分别为28例和17例,病灶水平真阳性分别为92个和65个,两种方法差异有统计学意义(p<0.05)。结论认为68Ga-DOTA-FAPI PET/CT优于18F-FDG PET/CT,尤其可作为18F-FDG阴性病例的补充手段。
要点
- 68Ga-DOTA-FAPI PET/CT在患者和病灶水平检测肝转移均优于18F-FDG PET/CT。
- 18F-FDG PET/CT阴性时,可考虑68Ga-DOTA-FAPI PET/CT补充检出肝转移。
- 两种方法病灶mlr值在所有肿瘤亚组中差异有统计学意义(p<0.05)。
核心结论
- 68Ga-DOTA-FAPI PET/CT在检测胃肠道肿瘤肝转移方面优于18F-FDG PET/CT,尤其可作为18F-FDG PET/CT阴性病例的补充方法。
研究设计与样本
- 本研究为诊断效能比较研究,纳入31例经68Ga-DOTA-FAPI和18F-FDG PET/CT检查的胃肠道肿瘤患者(15例结直肠癌、9例胰腺癌、4例胃癌、3例其他)。
- 肝转移诊断参考标准包括组织病理学诊断、PET/CT、其他影像学检查或肿瘤生物标志物结果,并按患者水平和病灶水平比较两种PET/CT的影像表现。
关键影像表现/征象
- 31例患者中,68Ga-DOTA-FAPI PET/CT检出28例真阳性,18F-FDG PET/CT检出17例真阳性。
- 按诊断标准确定的98个肝转移病灶中,68Ga-DOTA-FAPI PET/CT检出92个真阳性病灶,18F-FDG PET/CT检出65个真阳性病灶。
诊断标准与关键数值
- 患者水平和病灶水平比较中,两种显像方法差异均有统计学意义(p<0.05)。
- 病灶半定量值比较中,mlr值在所有肿瘤亚组中差异有统计学意义(p<0.05)。
临床应用与阅片要点
- 对于胃肠道肿瘤肝转移的检出,68Ga-DOTA-FAPI PET/CT可提高患者和病灶水平的检出率。
- 当18F-FDG PET/CT结果为阴性而临床仍怀疑肝转移时,可建议补充68Ga-DOTA-FAPI PET/CT检查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: We aimed to compare the diagnostic performance of PET/CT imaging performed with 68Ga-DOTA-FAPI and 18FDG in detection of liver metastases in patients with gastrointestinal system (GIS) cancer.
METHODS: A total of 31 patients who underwent 68Ga-DOTA-FAPI and 18F-FDG PET/CT examinations and diagnosed with GIS cancer (15 colorectal, 9 pancreas, 4 stomach and 3 other cancers) were included in the study. The presence of liver metastasis was decided based on histopathologic diagnosis, PET/CT, other radiologic examinations or tumor biomarker findings, and both PET/CT imaging findings were compared on the patient and lesion basis.
RESULTS: Of the 31 patients, 28 were found as true positive with 68Ga-DOTA-FAPI-PET/CT and 17 with 18FDG-PET/CT. Of the 98 metastatic liver lesions determined according to our diagnostic criteria, 92 were found as true positive lesions with 68Ga-DOTA-FAPI-PET/CT and 65 with 18FDG-PET/CT. There was a statistically significant difference between both imaging modalities in the patient and lesion based comparisons (p < 0.05). When semiquantitative values (SUVmax, mlr) obtained from the lesions were compared between the two imaging methods, mlr values showed statistically significant difference in all tumor subgroups (p < 0.05).
CONCLUSION: It was concluded that 68Ga-DOTA-FAPI-PET/CT was superior over 18FDG-PET/CT in detection of liver metastases of GIS cancers and it can be a complementary method especially in negative cases with 18FDG-PET/CT.
引用
- Şahin E, Elboğa U, Çelen YZ, et al. Comparison of 68Ga-DOTA-FAPI and 18FDG PET/CT imaging modalities in the detection of liver metastases in patients with gastrointestinal system cancer. Eur J Radiol. 2021. PMID: 34315086. doi:10.1016/j.ejrad.2021.109867
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。